| Name | Title | Contact Details |
|---|
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
Wellstart International Inc is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
CMC ICOS Biologics Inc. is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Bothell, WA. To find more information about CMC ICOS Biologics Inc., please visit www.cmcbio.com
RBC Product Development is a Lenexa, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mednational is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.